Sign In
Buy BSX
$48.85
+1.16 (+2.43%)
At Close: Jun 04, 2026
FDA classifies recall of Boston Scientific catheters as 'most serious'
04:16pm, Wednesday, 18'th Dec 2024
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as "most serious".
BSX Trades Near 52-Week High: Does the Stock Hold More Potential?
11:56am, Wednesday, 18'th Dec 2024
We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024.
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?
10:30am, Friday, 13'th Dec 2024
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes
10:31am, Thursday, 12'th Dec 2024
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States.
Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note
07:01pm, Wednesday, 11'th Dec 2024
Boston Scientific (BSX) closed the most recent trading day at $90.56, moving +0.4% from the previous trading session.
Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace
08:08am, Wednesday, 11'th Dec 2024
NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Today's Marketplace (TMP) is proud to announce a featured interview with Boston Scientific (NYSE: BSX) Global Chief Medical Officer, Kenneth Stein, MD, and Sc
Boston Scientific (BSX) Sees a More Significant Dip Than Broader Market: Some Facts to Know
07:00pm, Thursday, 05'th Dec 2024
Boston Scientific (BSX) closed at $90.53 in the latest trading session, marking a -0.34% move from the prior day.
International Expansion Supports BSX Stock Amid Macroeconomic Woes
10:50am, Tuesday, 26'th Nov 2024
BSX's Endoscopy business within MedSurg is gaining from strong worldwide demand for its broad range of gastrointestinal (GI) and pulmonary treatment options.
Brokers Suggest Investing in Boston Scientific (BSX): Read This Before Placing a Bet
10:31am, Tuesday, 26'th Nov 2024
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employe
BSX Stock Set to Gain From Agreement to Acquire Intera Oncology
09:25am, Tuesday, 26'th Nov 2024
Boston Scientific's new buyout is set to expand its interventional oncology offerings.
Boston Scientific Announces Agreement to Acquire Intera Oncology® Inc.
07:00am, Monday, 25'th Nov 2024
Acquisition to expand interventional oncology offerings with complementary therapy to treat liver-dominant metastases MARLBOROUGH, Mass. , Nov. 25, 2024 /PRNewswire/ -- Boston Scientific Corporation (
Why Is Boston Scientific (BSX) Up 7.5% Since Last Earnings Report?
12:37pm, Friday, 22'nd Nov 2024
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
BSX Stock Gains From Positive OPTION Trial Data for WATCHMAN FLX
09:26am, Tuesday, 19'th Nov 2024
Boston Scientific announces favorable OPTION trial results for its WATCHMAN FLX LAAC device. In terms of stroke risk reduction, WATCHMAN FLX is found to be superior to OAC therapy.
Reasons to Retain BSX Stock in Your Portfolio for Now
09:26am, Tuesday, 19'th Nov 2024
Investors remain optimistic about Boston Scientific due to its geographical expansions and impressive acquisitions.
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
08:50am, Tuesday, 19'th Nov 2024
BSX's acquisition of Axonics marks its entry into sacral neuromodulation and complements its Urology business.
